Journal
LUPUS
Volume 23, Issue 12, Pages 1259-1261Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0961203314534307
Keywords
Antiphospholipid syndrome; Hughes syndrome; cardiovascular disease
Categories
Ask authors/readers for more resources
Heart valve disease (HVD) is the most common cardiac manifestation in the antiphospholipid syndrome (APS). Valve lesions should be described according to the established definition. HVD is progressive despite anticoagulant/antiplatelet treatments. Around 4-6% of patients with HVD in APS will require valve replacement surgery, which is considered a very high risk procedure in APS. Unfortunately, no recommendations regarding medical treatment of antiphospholipid antibodies-associated HVD can be made at this moment. There are evidence-based data and strong pathophysiologic rationale for considering HVD as a manifestation of APS. Thus, HVD should be included as a criterion of definite APS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available